In the latest trading session,, 8.05 million Citius Pharmaceuticals Inc (NASDAQ:CTXR) shares changed hands as the company’s beta touched 0.86. With the company’s most recent per share price at $1.06 changing hands around $0.21 or 24.54% at last look, the market valuation stands at $10.91M. CTXR’s current price is a discount, trading about -2376.42% off its 52-week high of $26.25. The share price had its 52-week low at $0.65, which suggests the last value was 38.68% up since then.
Analysts gave the Citius Pharmaceuticals Inc (CTXR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.67. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CTXR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Citius Pharmaceuticals Inc (NASDAQ:CTXR) trade information
Instantly CTXR is in green as seen in intraday trades today. With action 37.67%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -73.50%, with the 5-day performance at 37.67% in the green. However, in the 30-day time frame, Citius Pharmaceuticals Inc (NASDAQ:CTXR) is 51.62% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 20.90%. The 2025 estimates are for Citius Pharmaceuticals Inc earnings to increase by 67.00%.
CTXR Dividends
Citius Pharmaceuticals Inc is expected to release its next quarterly earnings report in July.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.9776% or 6.33 million shares worth $3.69 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 165.58 shares estimated at $0.16 million under it, the former controlled 1.61% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.76% of the shares, roughly 78.31 shares worth around $73616.0.
